Benign splenic lesions in BAP1-tumor predisposition syndrome: a case series. Academic Article uri icon

Overview

abstract

  • BAP1-Tumor Predisposition Syndrome (TPDS) is caused by germline variants in BAP1 and predisposes to solid tumors. After observation of a radiologically malignant-appearing splenic mass with benign pathology in a patient with BAP1-TPDS, we sought to retrospectively characterize splenic lesions in individuals with BAP1-TPDS seen at a comprehensive cancer center. A dedicated radiology review for splenic abnormalities was performed. We identified 37 individuals with BAP1-TPDS, 81% with a history of cancer. Of 33 individuals with abdominal imaging, 10 (30%) had splenic lesions, and none were shown to be malignant on follow-up. Splenectomy in an individual with suspected splenic angiosarcoma showed a benign vascular neoplasm with loss of nuclear staining for BAP1 in a subset of cells. Benign splenic lesions appear to be common and potentially BAP1-driven in individuals with BAP1-TPDS; confirmation of these findings could lead to more conservative management and avoidance of splenectomy.

publication date

  • June 1, 2024

Research

keywords

  • Tumor Suppressor Proteins
  • Ubiquitin Thiolesterase

Identity

PubMed Central ID

  • PMC11291683

Scopus Document Identifier

  • 85194887394

Digital Object Identifier (DOI)

  • 10.1038/s41431-024-01623-w

PubMed ID

  • 38824259

Additional Document Info

volume

  • 32

issue

  • 8